Baseline characteristics of the patients and main results of the IMPACT study16
| Parameter | SMBG (n=80) | FM system (n=81) |
| Age, years: mean (range) | 44 (34–53) | 42 (32–53) |
| Duration of diabetes, years: mean (range) | 19 (11–31) | 19 (14–25) |
| Baseline HbA1c, %: mean±SD | 6.7±0.6 | 6.7±0.5 |
| Baseline daily frequency of SMBG: mean±SD | 5.6±1.9 | 5.5±2.0 |
| Final daily frequency of SMBG: mean±SD | 5.5±2.6 | 0.5±1.0 |
| Number of episodes with glucose <2.2 mmol/L (40 mg/dL): mean±SD | Baseline: 0.49±0.52 Final: 0.52±0.63 | Baseline: 0.44±0.48 Final: 0.20±0.32 |
| Difference FM vs SMBG: –58.6% | ||
| Number of episodes with glucose <3.9 mmol/L (70 mg/dL): mean±SD | Baseline: 1.72±0.75 Final: 1.78±0.78 | Baseline: 1.80±0.80 Final: 1.23±0.69 |
| Difference FM vs SMBG: –32.8% | ||
FM, flash monitoring; HbA1c, glycated hemoglobin; SMBG, self-monitoring of capillary blood glucose.